News Novartis app could revolutionise ophthalmic clinical trials Patients will be able to participate in clinical ophthalmology trials from home thanks to a groundbreaking digital app developed by Novartis.
Views & Analysis Digital health round-up: Could Nokia kill off digital health... Richard Staines gives a round-up of the latest developments in digital health over the last week.
News AI predicts heart attack risk factors from retinal scans Artificial Intelligence can be used to predict heart attack risk using retinal images, according to new research backed by Google.
News FDA makes history, approving Spark's eye gene therapy Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends